Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Waters

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
HIV Medicine|August 30, 2016
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015Duncan Churchill, Laura Waters, Nadia Ahmed, et al.
Biorxiv : the Preprint Server for Biology|November 16, 2022
Attenuated humoral responses in HIV infection after SARS-CoV-2 vaccination are linked to global B cell defects and cellular immune profilesEmma Touizer, Aljawharah Alrubbayi, Rosemarie Ford, et al.
HIV Medicine|July 27, 2012
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012Ian Williams, Duncan Churchill, Jane Anderson, et al.
HIV Medicine|December 17, 2013
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.), Ian Williams, Duncan Churchill, et al.
HIV Medicine|June 10, 2024
Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI-net)Kyle Ring, Melanie Smuk, Moses Shongwe, et al.
Iscience|January 2, 2023
Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profilesEmma Touizer, Aljawharah Alrubayyi, Rosemarie Ford, et al.
The Lancet. HIV|May 16, 2022
Unified European support framework to sustain the HIV cascade of care for people living with HIV including in displaced populations of war-struck UkraineMarta Vasylyev, Agata Skrzat-Klapaczyńska, Jose I Bernardino, et al.
Journal of Medicinal Chemistry|March 13, 2024
Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3Kα Mutant ProteinJohn M Ketcham, Stephen J Harwood, Ruth Aranda, et al.
Lancet (London, England)|February 24, 2023
Mpox in people with advanced HIV infection: a global case seriesOriol Mitjà, Andrea Alemany, Michael Marks, et al.
Molecular Cancer Therapeutics|June 21, 2024
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide LoadingNiranjan Sudhakar, Larry Yan, Fadia Qiryaqos, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
HIV Medicine|August 30, 2016
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015Duncan Churchill, Laura Waters, Nadia Ahmed, et al.
Biorxiv : the Preprint Server for Biology|November 16, 2022
Attenuated humoral responses in HIV infection after SARS-CoV-2 vaccination are linked to global B cell defects and cellular immune profilesEmma Touizer, Aljawharah Alrubbayi, Rosemarie Ford, et al.
HIV Medicine|July 27, 2012
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012Ian Williams, Duncan Churchill, Jane Anderson, et al.
HIV Medicine|December 17, 2013
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.), Ian Williams, Duncan Churchill, et al.
HIV Medicine|June 10, 2024
Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI-net)Kyle Ring, Melanie Smuk, Moses Shongwe, et al.
Iscience|January 2, 2023
Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profilesEmma Touizer, Aljawharah Alrubayyi, Rosemarie Ford, et al.
The Lancet. HIV|May 16, 2022
Unified European support framework to sustain the HIV cascade of care for people living with HIV including in displaced populations of war-struck UkraineMarta Vasylyev, Agata Skrzat-Klapaczyńska, Jose I Bernardino, et al.
Journal of Medicinal Chemistry|March 13, 2024
Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3Kα Mutant ProteinJohn M Ketcham, Stephen J Harwood, Ruth Aranda, et al.
Lancet (London, England)|February 24, 2023
Mpox in people with advanced HIV infection: a global case seriesOriol Mitjà, Andrea Alemany, Michael Marks, et al.
Molecular Cancer Therapeutics|June 21, 2024
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide LoadingNiranjan Sudhakar, Larry Yan, Fadia Qiryaqos, et al.
Pageof 14